Market Overview

Why BioNTech's Stock Is Trading Higher Today


BioNTech SE (NASDAQ: BNTX) shares are trading higher on Thursday, after the company said it would partner with Pfizer (NYSE: PFE) to initiate first clinical trials of the coronavirus vaccine as early as this month.

The company will receive $185 million upfront and is eligible for up to $563 million in milestones.

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases.

BioNTech SE shares were trading up 8.39% at $48.72 on Thursday. The stock has a 52-week high of $105 and a 52-week low of $12.52.


Related Articles (BNTX)

View Comments and Join the Discussion!

Posted-In: why it's movingBiotech News General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at